Sale!

ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ANKRD26 Gene Thrombocytopenia Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ANKRD26 gene, which are associated with Thrombocytopenia Type 2, a rare inherited blood disorder. This condition is characterized by a significantly reduced platelet count, leading to increased bleeding and bruising risks. The test is crucial for individuals with a family history of thrombocytopenia or those exhibiting symptoms, as it aids in confirming the diagnosis, understanding the risk of transmission to offspring, and facilitating personalized treatment plans. Priced at 4400 AED, the test is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANKRD26 Gene Thrombocytopenia type 2 Genetic Test

Test Name: ANKRD26 Gene Thrombocytopenia type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ANKRD26 Gene Thrombocytopenia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANKRD26 Gene Thrombocytopenia type 2 NGS Genetic DNA Test gene ANKRD26

Test Details

ANKRD26 gene thrombocytopenia type 2 is a genetic disorder characterized by a reduction in the number of blood cells called platelets, leading to a condition known as thrombocytopenia. Thrombocytopenia can cause excessive bleeding and bruising.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA sequence and identify any genetic mutations or variations that may be associated with a particular disorder or condition. In the case of ANKRD26 gene thrombocytopenia type 2, NGS genetic testing can be used to detect any mutations or variations in the ANKRD26 gene that may be causing the disorder.

By identifying the specific genetic mutation causing the thrombocytopenia, NGS genetic testing can help with the diagnosis of ANKRD26 gene thrombocytopenia type 2 and provide valuable information for treatment and management of the condition. It can also help in determining the risk of passing on the disorder to future generations and provide genetic counseling for affected individuals and their families.

Test Name ANKRD26 Gene Thrombocytopenia type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ANKRD26 Gene Thrombocytopenia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANKRD26 Gene Thrombocytopenia type 2 NGS Genetic DNA Test gene ANKRD26
Test Details

ANKRD26 gene thrombocytopenia type 2 is a genetic disorder characterized by a reduction in the number of blood cells called platelets, leading to a condition known as thrombocytopenia. Thrombocytopenia can cause excessive bleeding and bruising.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA sequence and identify any genetic mutations or variations that may be associated with a particular disorder or condition. In the case of ANKRD26 gene thrombocytopenia type 2, NGS genetic testing can be used to detect any mutations or variations in the ANKRD26 gene that may be causing the disorder.

By identifying the specific genetic mutation causing the thrombocytopenia, NGS genetic testing can help with the diagnosis of ANKRD26 gene thrombocytopenia type 2 and provide valuable information for treatment and management of the condition. It can also help in determining the risk of passing on the disorder to future generations and provide genetic counseling for affected individuals and their families.